Post Profile






MDs Say US Costs For Valeant's Lead Poisoning Drug Are 33,000% More Than Canada's

Why do Canadians pay so much less, and why has Valeant's price gone up so fast?
read more

share

Related Posts


Goldman Sachs sold 1.3 million of the Valeant CEO's shares of his company yesterday (VRX)

Business & Finance : Business Insider: Clusterstock

Embattled Canadian drug company Valeant Pharmaceutical's CEO J. Michael Pearson got a collateral call from Goldman Sachs. On April 22, 2014, when Valeant's share price was $206.93, Pearson pledged two million shares to Goldman in ex...

Bill Ackman explains how he'll make money on Valeant (VRX)

Business & Finance : Business Insider: Clusterstock

Bill Ackman, the activist investor who runs Pershing Square Capital Management, is confident that his money-losing bet in Canadian drug company Valeant Pharmaceuticals will eventually pay off. Valeant's turned into a disaster for Ac...

Valeant is getting hammered, again (VRX)

Business & Finance : Business Insider: Clusterstock

Embattled Canadian drug company Valeant Pharmaceuticals is getting hammered again. Valeant's stock fell below $30, hitting a 52-week low of $29.88, on Thursday. Valeant's share price was last trading down $3.15, or down 9.39%, at $3...

Valeant is calling in a hedge fund executive at its most testing time

Business & Finance : Business Insider: Money Game

Valeant Pharmaceuticals has added an activist hedge fund executive to its board a fter its stock tanked following a short-seller's research report. The Canadian drug company's share price has gone on a wild ride over the last week, ...

Drug maker draws fire over price hike for decades-old lead poisoning treament

Business & Finance : Mashable: Business

A drug used to treat lead poisoning is causing a toxic reaction among hospitals and poison control centers after Valeant Pharmaceuticals jacked up the price more than 2,700 percent in a single year. At issue is a decades-old, intrav...

Comments


Copyright © 2016 Regator, LLC